All the news Showing 10 of 102 articles from: Treatment outcomesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Curing hepatitis C reduces deaths and liver disease Keith Alcorn / 17 April 2018 Curing hepatitis C infection significantly reduces deaths from liver disease and reduces the incidence of decompensation, two large prospective studies from Italy and Scotland show. The findings were presented on ... The VA Will Eliminate Hepatitis C In Veterans By Year-end Forbes / 02 March 2018 Ethnic disparities evaporate with DAA treatment of hepatitis C infections ModernMedicine / 06 February 2018 Low skeletal muscle mass improves after successful HCV treatment Healio Hepatology / 22 November 2017 Fatty Liver Common After Direct-Acting Antivirals for Hep C Medscape (requires free registration) / 01 November 2017 Curing hepatitis C with DAAs linked to 71% reduction in liver cancer Liz Highleyman / 30 October 2017 People who achieved a sustained response to hepatitis C treatment lowered their risk of hepatocellular carcinoma by around 70%, regardless of whether they were treated with new direct-acting antivirals (DAAs) or older interferon-based therapy, ... Hepatitis C cure leads to improved quality of life Liz Highleyman / 23 October 2017 People who were cured of hepatitis C with direct-acting antivirals (DAAs) had sustained improvements in their health-related quality of life, including both physical and mental health measures, according to study ... Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment Michael Carter / 10 August 2017 For the first time, a large study has demonstrated that treatment with direct-acting antivirals (DAAs) significantly reduces mortality rates among people with hepatitis C virus (HCV) monoinfection. The study – ... Direct-acting antivirals successfully treating hepatitis C, says Public Health England Pharmaceutical Journal / 02 August 2017 HCV therapy with SVR reduces the risk of several non-liver-related diseases commonly seen in people with chronic HCV Michael Carter / 06 July 2017 The risk of several non-liver complications associated with chronic hepatitis C virus (HCV) infection is reduced after interferon-based treatment that achieves a sustained virological response (SVR), investigators from the United ... ← Prev1...23456...11Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive